Cai Lay Veterinary Pharmaceutical JSC (HNX:MKV)
Vietnam · Delayed Price · Currency is VND 13,200
0.00 (0.00%)
At close: Aug 26, 2026
HNX:MKV Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
| 66,000 | 75,500 | 49,000 | 54,000 | 55,000 | 60,000 | |
Market Cap Growth | 36.08% | 54.08% | -9.26% | -1.82% | -8.33% | -14.29% |
Enterprise Value | 25,408 | 39,015 | 33,097 | 94,004 | 95,004 | 91,367 |
Last Close Price | 13200.00 | 15100.00 | 9800.00 | 10800.00 | 10707.96 | 11681.42 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
PE Ratio | 4.43 | 4.47 | 6.69 | 8.71 | 9.32 | 33.95 |
PS Ratio | 0.43 | 0.50 | 0.46 | 0.49 | 0.46 | 0.59 |
PB Ratio | 0.62 | 0.73 | 0.56 | 0.68 | 0.75 | 1.13 |
P/TBV Ratio | 0.62 | 0.73 | 0.56 | 0.68 | 0.75 | 1.13 |
P/FCF Ratio | 2.29 | 3.86 | 8.76 | 2.21 | 7.82 | 2.74 |
P/OCF Ratio | 2.10 | 3.55 | 8.76 | 2.13 | 7.24 | 2.74 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
EV/Sales Ratio | 0.17 | 0.26 | 0.31 | 0.85 | 0.79 | 0.89 |
EV/EBITDA Ratio | 1.01 | 1.36 | 2.03 | 5.26 | 4.81 | 5.48 |
EV/EBIT Ratio | 1.21 | 1.59 | 2.74 | 8.79 | 7.96 | 11.26 |
EV/FCF Ratio | 0.88 | 1.99 | 5.91 | 3.85 | 13.51 | 4.17 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
Debt / Equity Ratio | - | - | - | - | 0.25 | 0.79 |
Debt / EBITDA Ratio | - | - | - | - | 0.93 | 2.51 |
Debt / FCF Ratio | - | - | - | - | 2.62 | 1.91 |
Net Debt / Equity Ratio | -0.38 | -0.31 | -0.24 | -0.19 | 0.11 | 0.76 |
Net Debt / EBITDA Ratio | -1.61 | -1.13 | -1.30 | -0.85 | 0.42 | 2.40 |
Net Debt / FCF Ratio | -1.41 | -1.66 | -3.78 | -0.62 | 1.17 | 1.83 |
Asset Turnover | 1.29 | 1.33 | 1.03 | 1.09 | - | 0.88 |
Inventory Turnover | 5.18 | 5.57 | 4.80 | 3.78 | - | 5.25 |
Quick Ratio | 4.65 | 4.85 | 2.66 | 2.61 | 1.10 | 0.70 |
Current Ratio | 6.26 | 7.29 | 3.45 | 3.35 | 2.10 | 1.08 |
Return on Equity (ROE) | 15.06% | 17.67% | 8.77% | 8.08% | - | 3.38% |
Return on Assets (ROA) | 11.01% | 13.60% | 7.25% | 6.54% | - | 4.35% |
Return on Invested Capital (ROIC) | 25.48% | 28.54% | 14.71% | 11.68% | 10.75% | 5.77% |
Return on Capital Employed (ROCE) | 19.80% | 23.60% | 13.80% | 13.40% | 15.90% | 11.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 25, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '19 Dec 31, 2019 |
Earnings Yield | 22.55% | 22.37% | 14.95% | 11.48% | 10.73% | 2.94% |
FCF Yield | 43.63% | 25.92% | 11.42% | 45.20% | 12.78% | 36.51% |
Payout Ratio | - | - | - | 24.19% | - | - |
Buyback Yield / Dilution | 0.09% | - | - | -0.02% | - | - |